LFB finalist of the 12th International Prix Galien

October 4th, 2012- Lyon hosted the 43rd Prix Galien France and the12th Prix Galien international with more than 300 people present to this ceremony. President François HOLLANDE, having agreed to grant his Patronage to this event and also the messages of support from Mr Ban Ki MOON, Secretary general from ONU,Commissioner Maire GEOGHEGAN-QUINN, European Commissioner for Research, Innovation and Sciences and MrElie WIESEL,Nobel laureate. This ceremony was under the presidency of Senator-MayorGérard COLLOMB, President of the « Grand Lyon ».

For this edition, 12 groups, all having won a national Prix Galien in 2011, were in competition: Novartis, Shire, Boehringer Ingelheim, Pfizer, Servier, Fresenius Biotech, Roche, Merck, Jansen, Celgene and LFB group.

In 2011, The Prix Galien France was awarded the LFB group in the « Medicine for the Treatment of Rare Diseases » category for its human fibrinogen.

The international trophy was delayed to Janssen laboratories for its speciality intended for the treatment of moderate to severe psoriasis.